Skip to main content
. 2016 Apr 29;6(4):e010664. doi: 10.1136/bmjopen-2015-010664

Table 2.

Prevalence of opioid use, mean daily oral morphine equivalents use, and days of use pre-THA and post-THA by opioid user status, and change in daily use and days by pre-THA to post-THA status

  Opioid use post-THA Opioid use pre-THA
Total None Some Chronic
Prevalence, n (%)
 Total 9525 5138 (5339) 3794 (39.8) 593 (6.2)
 None 6626 (69.6) 4369 (85.0) 2146 (56.6) 111 (18.7)
 Some 2407 (25.3) 731 (14.2) 1496 (39.4) 180 (30.4)
 Chronic 492 (5.2) 38 (0.7) 152 (4.0) 302 (50.9)
Daily OME use for group and change in daily OME use,* mg, mean (95% CI)
 Total 0.0 (0.0 to 0.0) 38.3 (37.6 to 39.0) 55.5 (51.4 to 59.7)
 None 0.0 (0.0 to 0.0) 0.0 (−0.1 to 0.1) −37.7 (−38.4 to −37.0) −55.3 (−59.4 to −51.2)
 Some 37.5 (36.6 to 38.4) 36.6 (35.7 to 37.5) −1.1 (−2.1 to −0.1) −18.7 (−22.9 to −14.5)
 Chronic 57.5 (52.1 to 62.8) 56.2 (51.2 to 61.2) 18.6 (13.6 to 23.6) 0.9 (−3.2 to 5.0)
Days using opioids for group and change in days use,* mean (95% CI)
 Total 0.0 (0.0 to 0.0) 27.0 (26.1 to 27.9) 189.9 (185.9 to 193.9)
 None 0.0 (0.0 to 0.0) −0.2 (−0.3 to −0.1) −25.9 (−26.8 to −25.0) −187.0 (−190.9 to −183.1)
 Some 24.4 (23.3 to 25.5) 22.7 (21.6 to 23.8) −3.0 (−4.3 to −1.7) −164.0 (−168.1 to −159.9)
 Chronic 193.0 (188.8 to 197.1) 189.0 (184.8 to 193.2) 163.3 (159.1 to 167.5) 2.6 (−2.3 to 7.5)

*Adjusted for age, sex, surgical indication, bilateral status, RxRisk-V comorbidity burden, back pain, year of operation, and prior THA and post-THA other analgesic medication use.

OME, oral morphine equivalents; THA, total hip arthroplasty.